Ca15-3 Levels
Ca15-3 Levels - Related Videos
07:59
Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 (BSL-3) Conditions
0 Views •
Cited by 2 •
2021
This protocol describes how to infect human intestinal organoids from either their apical or basolateral side to characterize host/pathogen interactions at the single-cell level using single-cell RNA sequencing (scRNAseq) technology.
08:30
Monovalent Cation Doping of CH3NH3PbI3 for Efficient Perovskite Solar Cells
0 Views •
Cited by 31 •
2017
Here, we present a protocol to adjust the properties of solution-processed CH3NH3PbI3 through the incorporation of monovalent cation additives in order to achieve highly efficient perovskite solar cells.
01:29
Leveling Effect
0 Views •
2024
In acid-base chemistry, the leveling effect refers to the limitation imposed by the solvent on the strength of acids and bases in solution. When a base stronger than the solvent's conjugate base is used, it deprotonates the solvent until the base is entirely consumed, making it ineffective against weaker acids. Conversely, an acid stronger than the solvent's conjugate acid protonates the solvent until the acid is depleted, rendering it ineffective against weaker bases. Essentially, the solvent...
01:19
High-Level and Low-Level Awareness
0 Views •
2024
Controlled processes in human consciousness represent high-alert mental states where individuals deliberately focus their attention on achieving specific goals. Controlled processes can be seen in situations like mastering new technology, where a person might become so absorbed that they ignore surrounding distractions. Such processes involve selective attention, requiring one to concentrate on particular elements of experience while disregarding others. These are governed by executive...
09:00
Lewis Acid-Base Interaction in Ph3P-BH3
0 Views •
2023
Source: Tamara M. Powers, Department of Chemistry, Texas A&M University One of the goals of chemistry is to use models that account for trends and provide insights into the properties of reactants that contribute to reactivity. Substances have been classified as acids and bases since the time of the ancient Greeks, but the definition of acids and bases has been modified and expanded over the years.1 The ancient Greeks would characterize substances by taste, and defined acids as those that...
FAQs
A single CA 15-3 result provides limited information because the marker can be elevated in benign conditions or in cancers other than breast cancer. Comparing concentrations over time gives clinicians a pattern to assess alongside the patient’s clinical findings and imaging. This approach helps distinguish changing disease activity from an isolated, nonspecific measurement.
CA 15-3 levels may rise in benign conditions as well as in other cancers, so an elevated result does not identify one specific cause. The measurement must therefore be interpreted in the broader clinical context rather than treated as proof of breast cancer. This limitation is why the test is not suitable as a standalone diagnostic tool.
CA 15-3 is not recommended for screening because an elevated level can occur without the specific cancer being investigated, while the result alone does not establish a diagnosis. Its value comes from monitoring patterns in an appropriate clinical setting, not from using one blood measurement to determine whether someone has cancer.
Clinicians measure CA 15-3 in a blood sample and then compare the concentration with measurements obtained over time. Interpretation does not rely on the laboratory value alone; imaging and clinical findings provide complementary evidence. This combined assessment allows the marker to support evaluation of disease activity without making it the sole basis for a medical conclusion.
During cancer care, changes in CA 15-3 levels can contribute to an assessment of whether disease activity is responding to treatment. The pattern is interpreted with imaging and clinical findings rather than in isolation. Used this way, serial measurements can provide additional information about the course of treatment, while avoiding conclusions based on a single result.
Changing CA 15-3 levels may help clinicians monitor possible recurrence or track advanced disease, particularly in the context of breast cancer. The marker serves as one part of follow-up and disease assessment, alongside imaging and clinical evaluation. Because elevations are not specific, a change in the level should be considered supporting information rather than definitive evidence by itself.